Christiansen P, Steiniche T, Brixen K, Hessov I, Melsen F, Heickendorff L, Mosekilde L
University Department of Surgery, Aarhus Amtssygehus, Denmark.
Bone. 1999 Nov;25(5):589-95. doi: 10.1016/s8756-3282(99)00207-0.
Changes in skeletal remodeling (biochemical bone markers) and regional bone mineral density (spine, hip, and forearm bone mineral density [BMD]) were observed for 3 years in 20 patients (15 women and 5 men; age 54 +/- 11 years, range 29-69 years) after successful surgery for primary hyperparathyroidism (PHPT). Fifteen PHPT patients were compared with 15 normal controls who were exactly matched with respect to age, gender, and menopausal status (10 women and 5 men; age 53 +/- 12 years, range 29-65 years [PHPT] and 29-66 years [controls]). All bone markers (serum osteocalcin, bone alkaline phosphatase, and type I collagen telopeptide [ICTP], and urinary hydroxyproline and NTx/creatinine ratio) declined significantly and reached normal levels within 6 months. No major changes took place during the remaining 2.5 years, apart from urine hydroxyproline, which disclosed a small peak around 12 months with a further decline towards study end (p < 0.05). Bone mineral density increased significantly in all regions (p < 0.001). At all locations, except the intertrochanteric region of the hip, the increase continued from 6 months until study end (p < 0.05). The increase in BMD was unequally distributed among regions (p < 0.001). The increase at the proximal forearm was less than in the spine (p < 0.05), the trochanteric region of the hip (p < 0.05), and the distal forearm (p < 0.05). No difference in BMD increase was observed between men, and pre- and postmenopausal women. Compared with the matched control group, PHPT patients had significantly lower BMD at baseline in the proximal (p < 0.02) and distal (p < 0.05) forearm. Furthermore, during the 3-year follow-up period, the PHPT patients showed a significant increase in BMD compared with controls in the spine (p < 0.005), the trochanteric and intertrochanteric regions of the hip (p < 0.005 and p < 0.05, respectively), and the distal forearm (p < 0.005). In conclusion, bone remodeling is normalized within the first 6 months after successful parathyroid surgery, with no major changes during the following 2.5 years. Bone mineral density increases at both cancellous and cortical sites, but in predominantly cortical bone, the recovery in BMD is less than in cancellous bone-rich areas.
对20例原发性甲状旁腺功能亢进症(PHPT)患者(15例女性和5例男性;年龄54±11岁,范围29 - 69岁)成功进行手术后,观察其骨骼重塑(生化骨标志物)和局部骨矿物质密度(脊柱、髋部和前臂骨矿物质密度[BMD])的变化情况,为期3年。将15例PHPT患者与15例正常对照者进行比较,这些对照者在年龄、性别和绝经状态方面完全匹配(10例女性和5例男性;年龄53±12岁,范围29 - 65岁[PHPT组]和29 - 66岁[对照组])。所有骨标志物(血清骨钙素、骨碱性磷酸酶、I型胶原末端肽[ICTP]、尿羟脯氨酸以及NTx/肌酐比值)均显著下降,并在6个月内恢复至正常水平。在剩余的2.5年中,除尿羟脯氨酸外无重大变化,尿羟脯氨酸在12个月左右出现一个小高峰,随后在研究结束时进一步下降(p < 0.05)。所有部位的骨矿物质密度均显著增加(p < 0.001)。在所有部位,除髋部转子间区域外,骨矿物质密度从6个月起持续增加直至研究结束(p < 0.05)。骨矿物质密度的增加在各部位分布不均(p < 0.001)。近端前臂的增加幅度小于脊柱(p < 0.05)、髋部转子区(p < 0.05)和远端前臂(p < 0.05)。男性、绝经前和绝经后女性之间在骨矿物质密度增加方面未观察到差异。与匹配的对照组相比,PHPT患者近端(p < 0.02)和远端(p < 0.05)前臂的基线骨矿物质密度显著较低。此外,在3年的随访期内,与对照组相比,PHPT患者在脊柱(p < 0.005)、髋部转子区和转子间区域(分别为p < 0.005和p < 0.05)以及远端前臂(p < 0.005)的骨矿物质密度显著增加。总之,甲状旁腺手术成功后的前6个月内骨骼重塑恢复正常,在随后的2.5年中无重大变化。松质骨和皮质骨部位的骨矿物质密度均增加,但在主要为皮质骨的部位,骨矿物质密度的恢复低于富含松质骨的区域。